Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.

---

Budde L. E., Zhang H., Kim W., Maruyama D., Rego E. M., Norasetthada L., ...More

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume:
• Publication Date: 2025
• Doi Number: 10.1200/jco-25-01957
• Journal Name: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
• Ankara University Affiliated: Yes